Search results:

Gene ID	Symbol	Synonyms	Official Full Name	Location
The pahtway p300 has 87 genes in the original annotation. Currently, there are 68 genes in SZGR (with evidence in schizophrenia) that are present at this pathway.
1326	MAP3K8	AURA2 \| COT \| EST \| ESTF \| MEKK8 \| TPL2 \| Tpl-2 \| c-COT	mitogen-activated protein kinase kinase kinase 8	10p11.23
5599	MAPK8	JNK \| JNK-46 \| JNK1 \| JNK1A2 \| JNK21B1/2 \| PRKM8 \| SAPK1 \| SAPK1c	mitogen-activated protein kinase 8	10q11.22
1147	CHUK	IKBKA \| IKK-alpha \| IKK1 \| IKKA \| NFKBIKA \| TCF16	conserved helix-loop-helix ubiquitous kinase	10q24-q25
3265	HRAS	C-BAS/HAS \| C-H-RAS \| C-HA-RAS1 \| CTLO \| H-RASIDX \| HAMSV \| HRAS1 \| RASH1 \| p21ras	Harvey rat sarcoma viral oncogene homolog	11p15.5
8986	RPS6KA4	MSK2 \| RSK-B \| S6K-alpha-4	ribosomal protein S6 kinase A4	11q11-q13
5970	RELA	NFKB3 \| p65	v-rel avian reticuloendotheliosis viral oncogene homolog A	11q13
4296	MAP3K11	MEKK11 \| MLK-3 \| MLK3 \| PTK1 \| SPRK	mitogen-activated protein kinase kinase kinase 11	11q13.1-q13.3
6199	RPS6KB2	KLS \| P70-beta \| P70-beta-1 \| P70-beta-2 \| S6K-beta2 \| S6K2 \| SRK \| STK14B \| p70(S6K)-beta \| p70S6Kb	ribosomal protein S6 kinase B2	11q13.2
5058	PAK1	PAKalpha	p21 protein (Cdc42/Rac)-activated kinase 1	11q13.5-q14.1
7786	MAP3K12	DLK \| MEKK12 \| MUK \| ZPK \| ZPKP1	mitogen-activated protein kinase kinase kinase 12	12q13
6667	SP1	-	Sp1 transcription factor	12q13.1
8550	MAPKAPK5	MAPKAP-K5 \| MK-5 \| MK5 \| PRAK	mitogen-activated protein kinase-activated protein kinase 5	12q24.13
4792	NFKBIA	IKBA \| MAD-3 \| NFKBI	NFKB inhibitor alpha	14q13
11183	MAP4K5	GCKR \| KHS \| KHS1 \| MAPKKKK5	mitogen-activated protein kinase kinase kinase kinase 5	14q22.1
4149	MAX	bHLHd4	MYC associated factor X	14q23
7043	TGFB3	ARVD \| ARVD1 \| LDS5 \| RNHF \| TGF-beta3	transforming growth factor beta 3	14q24
4293	MAP3K9	MEKK9 \| MLK1 \| PRKE1	mitogen-activated protein kinase kinase kinase 9	14q24.2
2353	FOS	AP-1 \| C-FOS \| p55	FBJ murine osteosarcoma viral oncogene homolog	14q24.3
5604	MAP2K1	CFC3 \| MAPKK1 \| MEK1 \| MKK1 \| PRKMK1	mitogen-activated protein kinase kinase 1	15q22.1-q22.33
5607	MAP2K5	HsT17454 \| MAPKK5 \| MEK5 \| PRKMK5	mitogen-activated protein kinase kinase 5	15q23
4205	MEF2A	ADCAD1 \| RSRFC4 \| RSRFC9 \| mef2	myocyte enhancer factor 2A	15q26
5595	MAPK3	ERK-1 \| ERK1 \| ERT2 \| HS44KDAP \| HUMKER1A \| P44ERK1 \| P44MAPK \| PRKM3 \| p44-ERK1 \| p44-MAPK	mitogen-activated protein kinase 3	16p11.2
5598	MAPK7	BMK1 \| ERK4 \| ERK5 \| PRKM7	mitogen-activated protein kinase 7	17p11.2
5606	MAP2K3	MAPKK3 \| MEK3 \| MKK3 \| PRKMK3 \| SAPKK-2 \| SAPKK2	mitogen-activated protein kinase kinase 3	17q11.2
9020	MAP3K14	FTDCR1B \| HS \| HSNIK \| NIK	mitogen-activated protein kinase kinase kinase 14	17q21
4215	MAP3K3	MAPKKK3 \| MEKK3	mitogen-activated protein kinase kinase kinase 3	17q23.3
2885	GRB2	ASH \| EGFRBP-GRB2 \| Grb3-3 \| MST084 \| MSTP084 \| NCKAP2	growth factor receptor bound protein 2	17q24-q25
5608	MAP2K6	MAPKK6 \| MEK6 \| MKK6 \| PRKMK6 \| SAPKK-3 \| SAPKK3	mitogen-activated protein kinase kinase 6	17q24.3
5596	MAPK4	ERK-4 \| ERK4 \| PRKM4 \| p63-MAPK \| p63MAPK	mitogen-activated protein kinase 4	18q21.1
5605	MAP2K2	CFC4 \| MAPKK2 \| MEK2 \| MKK2 \| PRKMK2	mitogen-activated protein kinase kinase 2	19p13.3
5609	MAP2K7	JNKK2 \| MAPKK7 \| MEK \| MEK 7 \| MKK7 \| PRKMK7 \| SAPKK-4 \| SAPKK4	mitogen-activated protein kinase kinase 7	19p13.3-p13.2
7040	TGFB1	CED \| DPD1 \| LAP \| TGFB \| TGFbeta	transforming growth factor beta 1	19q13.1
1050	CEBPA	C/EBP-alpha \| CEBP	CCAAT/enhancer binding protein alpha	19q13.1
11184	MAP4K1	HPK1	mitogen-activated protein kinase kinase kinase kinase 1	19q13.1-q13.4
4294	MAP3K10	MEKK10 \| MLK2 \| MST	mitogen-activated protein kinase kinase kinase 10	19q13.2
6195	RPS6KA1	HU-1 \| MAPKAPK1A \| RSK \| RSK1 \| p90Rsk	ribosomal protein S6 kinase A1	1p
9064	MAP3K6	ASK2 \| MAPKKK6 \| MEKK6	mitogen-activated protein kinase kinase kinase 6	1p36.11
4209	MEF2D	-	myocyte enhancer factor 2D	1q12-q23
9261	MAPKAPK2	MAPKAP-K2 \| MK-2 \| MK2	mitogen-activated protein kinase-activated protein kinase 2	1q32
5594	MAPK1	ERK \| ERK-2 \| ERK2 \| ERT1 \| MAPK2 \| P42MAPK \| PRKM1 \| PRKM2 \| p38 \| p40 \| p41 \| p41mapk \| p42-MAPK	mitogen-activated protein kinase 1	22q11.21
5600	MAPK11	P38B \| P38BETA2 \| PRKM11 \| SAPK2 \| SAPK2B \| p38-2 \| p38Beta	mitogen-activated protein kinase 11	22q13.33
6300	MAPK12	ERK-6 \| ERK3 \| ERK6 \| MAPK 12 \| P38GAMMA \| PRKM12 \| SAPK-3 \| SAPK3	mitogen-activated protein kinase 12	22q13.33
9448	MAP4K4	FLH21957 \| HEL-S-31 \| HGK \| MEKKK4 \| NIK	mitogen-activated protein kinase kinase kinase kinase 4	2q11.2-q12
10746	MAP3K2	MEKK2 \| MEKK2B	mitogen-activated protein kinase kinase kinase 2	2q14.3
1386	ATF2	CRE-BP1 \| CREB-2 \| CREB2 \| HB16 \| TREB7	activating transcription factor 2	2q32
6772	STAT1	CANDF7 \| IMD31A \| IMD31B \| IMD31C \| ISGF-3 \| STAT91	signal transducer and activator of transcription 1	2q32.2
1385	CREB1	CREB \| CREB-1	cAMP responsive element binding protein 1	2q34
7867	MAPKAPK3	3PK \| MAPKAP-K3 \| MAPKAP3 \| MAPKAPK-3 \| MK-3	mitogen-activated protein kinase-activated protein kinase 3	3p21.3
5894	RAF1	CMD1NN \| CRAF \| NS5 \| Raf-1 \| c-Raf	Raf-1 proto-oncogene, serine/threonine kinase	3p25
5062	PAK2	PAK65 \| PAKgamma	p21 protein (Cdc42/Rac)-activated kinase 2	3q29
5602	MAPK10	JNK3 \| JNK3A \| PRKM10 \| SAPK1b \| p493F12 \| p54bSAPK	mitogen-activated protein kinase 10	4q22.1-q23
4790	NFKB1	CVID12 \| EBP-1 \| KBF1 \| NF-kB1 \| NF-kappa-B \| NF-kappaB \| NFKB-p105 \| NFKB-p50 \| NFkappaB \| p105 \| p50	nuclear factor of kappa light polypeptide gene enhancer in B-cells 1	4q24
9693	RAPGEF2	CNrasGEF \| NRAPGEP \| PDZ-GEF1 \| PDZGEF1 \| RA-GEF \| RA-GEF-1 \| Rap-GEP \| nRap GEP	Rap guanine nucleotide exchange factor 2	4q32.1
4214	MAP3K1	MAPKKK1 \| MEKK \| MEKK 1 \| MEKK1 \| SRXY6	mitogen-activated protein kinase kinase kinase 1	5q11.2
4208	MEF2C	C5DELq14.3 \| DEL5q14.3	myocyte enhancer factor 2C	5q14.3
1616	DAXX	BING2 \| DAP6 \| EAP1	death-domain associated protein	6p21.3
1432	MAPK14	CSBP \| CSBP1 \| CSBP2 \| CSPB1 \| EXIP \| Mxi2 \| PRKM14 \| PRKM15 \| RK \| SAPK2A \| p38 \| p38ALPHA	mitogen-activated protein kinase 14	6p21.3-p21.2
8737	RIPK1	RIP \| RIP-1 \| RIP1	receptor interacting serine/threonine kinase 1	6p25.2
6885	MAP3K7	MEKK7 \| TAK1 \| TGF1a	mitogen-activated protein kinase kinase kinase 7	6q15
4217	MAP3K5	ASK1 \| MAPKKK5 \| MEKK5	mitogen-activated protein kinase kinase kinase 5	6q22.33
6196	RPS6KA2	HU-2 \| MAPKAPK1C \| RSK \| RSK3 \| S6K-alpha \| S6K-alpha2 \| p90-RSK3 \| p90RSK2 \| pp90RSK3	ribosomal protein S6 kinase A2	6q27
5879	RAC1	MIG5 \| Rac-1 \| TC-25 \| p21-Rac1	ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)	7p22
673	BRAF	B-RAF1 \| BRAF1 \| NS7 \| RAFB1	B-Raf proto-oncogene, serine/threonine kinase	7q34
3551	IKBKB	IKK-beta \| IKK2 \| IKKB \| IMD15 \| NFKBIKB	inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta	8p11.2
4609	MYC	MRTL \| MYCC \| bHLHe39 \| c-Myc	v-myc avian myelocytomatosis viral oncogene homolog	8q24.21
7186	TRAF2	MGC:45012 \| TRAP \| TRAP3	TNF receptor associated factor 2	9q34
2002	ELK1	-	ELK1, ETS transcription factor	Xp11.2
6197	RPS6KA3	CLS \| HU-3 \| ISPK-1 \| MAPKAPK1B \| MRX19 \| RSK \| RSK2 \| S6K-alpha3 \| p90-RSK2 \| pp90RSK2	ribosomal protein S6 kinase A3	Xp22.2-p22.1